Papp, Z. Agostoni, P. Alvarez, J. Bettex, D. Bouchez, S. Brito, D. Černý, V. Comin-Colet, J. Crespo-Leiro, M.G. Delgado, J.F. Édes, I. Eremenko, A.A. Farmakis, D. Fedele, F. Fonseca, C. Fruhwald, S. Girardis, M. Guarracino, F. Harjola, V.-P. Heringlake, M. Herpain, A. Heunks, L.M.A. Husebye, T. Ivancan, V. Karason, K. Kaul, S. Kivikko, M. Kubica, J. Masip, J. Matskeplishvili, S. Mebazaa, A. Nieminen, M.S. Oliva, F. Papp, J.G. Parissis, J. Parkhomenko, A. Põder, P. Pölzl, G. Reinecke, A. Ricksten, S.-E. Riha, H. Rudiger, A. Sarapohja, T. Schwinger, R.H.G. Toller, W. Tritapepe, L. Tschöpe, C. Wikström, G. Lewinski, D.V. Vrtovec, B. Pollesello, P., Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use, Journal of Cardiovascular Pharmacology, (76), 4-22, 2020, Lippincott Williams and Wilkins, 0160-2446, 1533-4023